CSPC Pharmaceutical Group Limited: Diabetes Mellitus, Type 2 trials
The registry lists 15 Diabetes Mellitus, Type 2 studies with CSPC Pharmaceutical Group Limited as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 5Phase 3 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or MetforminNot yet recruitingNCT07796477Phase 2
- A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 DiabetesActive, not recruitingNCT07026968Phase 3
- A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes MellitusCompletedNCT06258148Phase 3
- A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes MellitusCompletedNCT06235086Phase 3
- Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes MellitusCompletedNCT06161844Phase 3
- A Study of TG103 Injection in Type 2 Diabetes SubjectsStatus unknownNCT05348122Phase 2
- A Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of DBPR108 Tablets in Type 2 Diabetes Mellitus PatientsCompletedNCT05146869Phase 1
- A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 DiabetesStatus unknownNCT05063253Phase 2
- A Study of TG103 in Subjects With Type 2 DiabetesStatus unknownNCT04790006Phase 1
- A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DMCompletedNCT04218734Phase 3
- A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus PatientsCompletedNCT04161430Phase 3
- DBPR108 Tablets in Type 2 Diabetes Mellitus PatientsCompletedNCT04124484Phase 2
- Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 DiabetesCompletedNCT03940183Phase 3
- The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes MellitusStatus unknownNCT03239119Phase 3
- The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes MellitusStatus unknownNCT01342042Phase 2